| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.fortishealthcare.com | |
| Market Cap | 33,444.65 Cr. | |
| Enterprise Value(EV) | 33,842.65 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 7.32 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 60.51 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 67.10 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 102.52 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 4.32 | Calculated using Price: 443.00 |
| Dividend Yield | 0.23 | Period Ending 2023-03 |
| No. of Shares Subscribed | 75.50 Cr. | 754,958,148 Shares |
| FaceValue | 10 | |
| About Fortis Healthcare Ltd. | ||
| The company is a leading integrated healthcare delivery service provider. The Company is primarily engaged in the business of healthcare services. The Company holds interests in its subsidiaries, associates and joint ventures which manages and operates a network of multi-specialty hospitals and diagnostics centres. | ||
| 1 Day |
|
-1.14% |
| 1 Week |
|
+0.85% |
| 1 Month |
|
+9.92% |
| 3 Month |
|
+3.23% |
| 6 Month |
|
+36.86% |
| 1 Year |
|
+67.65% |
| 2 Year |
|
+62.12% |
| 5 Year |
|
+219.69% |
| 10 Year |
|
+340.01% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | -3.94 | 0.97 | 10.33 | -20.4 | -4.22 | 1.38 | -0.88 | 12.85 | 9.44 | |
| Return on Capital Employed (%) | -0.12 | 2.64 | 11.72 | -9.77 | 3.11 | 5.36 | 2.72 | 15.61 | 12.5 | |
| Return on Assets (%) | -2.13 | 0.54 | 5.81 | -10.49 | -2.26 | 0.82 | -0.52 | 7.08 | 5.36 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 4,718 | 4,461 | 5,143 | 4,062 | 6,601 | 6,661 | 6,120 | 6,178 | 7,242 | 7,610 | |
| Non Curr. Liab. | 1,112 | 704 | 1,247 | 876 | 782 | 1,170 | 2,834 | 3,238 | 2,563 | 1,055 | |
| Curr. Liab. | 1,602 | 1,450 | 1,881 | 2,133 | 3,591 | 2,578 | 1,232 | 1,268 | 1,314 | 2,914 | |
| Minority Int. | 153 | 392 | 1,167 | 1,255 | 512 | 545 | 598 | 830 | 858 | 870 | |
| Equity & Liab. | 7,585 | 7,007 | 9,484 | 8,327 | 11,486 | 10,955 | 10,784 | 11,516 | 12,089 | 12,449 | |
| Non Curr. Assets | 5,948 | 5,592 | 7,709 | 7,045 | 9,819 | 10,014 | 9,748 | 10,382 | 10,683 | 11,190 | |
| Curr. Assets | 1,636 | 1,414 | 1,728 | 1,278 | 1,666 | 938 | 1,033 | 1,130 | 1,150 | 1,259 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 7,585 | 7,007 | 9,484 | 8,327 | 11,486 | 10,955 | 10,784 | 11,516 | 12,089 | 12,449 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 3,966 | 4,199 | 4,574 | 4,561 | 4,469 | 4,632 | 4,030 | 5,718 | 6,298 | 6,750 | |
| Other Income | 96 | 154 | 166 | 140 | 92 | 53 | 47 | 27 | 62 | 42 | |
| Total Income | 4,062 | 4,352 | 4,740 | 4,701 | 4,562 | 4,685 | 4,077 | 5,745 | 6,359 | 6,792 | |
| Total Expenditure | -3,835 | -3,995 | -4,221 | -4,288 | -4,244 | -4,023 | -3,626 | -4,649 | -5,196 | -5,592 | |
| PBIDT | 226 | 358 | 519 | 413 | 318 | 662 | 451 | 1,096 | 1,163 | 1,200 | |
| Interest | -152 | -133 | -229 | -258 | -337 | -205 | -166 | -147 | -129 | -128 | |
| Depreciation | -235 | -225 | -222 | -239 | -233 | -292 | -291 | -301 | -316 | -332 | |
| Taxation | -5 | 8 | -72 | -23 | -114 | -148 | -99 | -198 | -181 | -190 | |
| Exceptional Items | 0 | -40 | -2 | -881 | -222 | 62 | 1 | 315 | 74 | 23 | |
| PAT | -164 | 40 | 479 | -934 | -224 | 91 | -56 | 790 | 633 | 573 | |
| Minority Interest | -14 | -23 | -58 | -75 | -75 | -34 | -54 | -235 | -44 | -28 | |
| Share Associate | 59 | 7 | |||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | -144 | 18 | 422 | -1,009 | -299 | 58 | -110 | 555 | 589 | 553 | |
| Adjusted EPS | -3 | 0 | 8 | -19 | -4 | 1 | -1 | 7 | 8 | 7 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 479 | 24 | 195 | 966 | 493 | -179 | 172 | 485 | 865 | 822 | |
| Cash Fr. Inv. | 2,669 | 213 | 113 | -1,002 | -335 | -3,323 | 60 | -135 | -514 | -374 | |
| Cash Fr. Finan. | -3,217 | -304 | -354 | 259 | -672 | 4,257 | -862 | -143 | -517 | -471 | |
| Net Change | -69 | -67 | -47 | 224 | -515 | 755 | -630 | 207 | -166 | -23 | |
| Cash & Cash Eqvt | 249 | 183 | 142 | 348 | -165 | 634 | 7 | 219 | 67 | 45 |
|
Thu, 18 Apr 2024
Updates Fortis Healthcare Limited has informed the Exchange regarding 'A detailed disclosure with respect to adjustment in open offer price of Fortis Malar Hospitals Limited (a Step down subsidiary of the Company) is attached'. |
|
Mon, 08 Apr 2024
Disclosure under SEBI Takeover Regulations ￂﾠNorthern TK Venture Pte. Ltd.ￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
Fri, 05 Apr 2024
Updates Fortis Healthcare Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015 regarding an order of Hon ble High Court Delhi received by Escorts HeartInstitute and Research Centre Limited, a wholly owned subsidiary of the Company'. |
| Thu, 25 Apr 2024 |
High Delivery Percentage
|
Closing Below Previous Low
|
Close Within 52 Week High Zone
|
High Increase in 1 Month
|
High Increase in 6 Months
|
